Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:00 pm Sale | 2025-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Stonepine Capital Management LLC | 156,179 2.100% | -221,061 (-58.60%) | Filing History |
| 2026-02-09 2:39 pm Purchase | 2025-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BML Investment Partners L.P. | 720,787 9.800% | 352,193 (+95.55%) | Filing History |
| 2025-11-14 1:33 pm Unchanged | 2025-09-30 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-09-08 5:44 pm Purchase | 2025-09-02 | 13G | Kezar Life Sciences, Inc. KZR | Stonepine Capital Management LLC | 377,240 5.200% | 377,240 (New Position) | Filing History |
| 2025-03-21 5:54 pm Unchanged | 2024-09-30 | 13G | Kezar Life Sciences, Inc. KZR | BARCLAYS PLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-03-06 5:46 pm Purchase | 2025-02-28 | 13G | Kezar Life Sciences, Inc. KZR | BML Investment Partners L.P. | 368,594 5.100% | 368,594 (New Position) | Filing History |
| 2025-03-03 4:01 pm Purchase | 2025-02-28 | 13D | Kezar Life Sciences, Inc. KZR | Equal Talent Investments Limited | 616,502 8.660% | 616,502 (New Position) | Filing History |
| 2025-02-14 10:42 am Purchase | 2024-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 502,600 6.900% | 502,600 (New Position) | Filing History |
| 2025-01-16 6:33 pm Purchase | 2024-12-03 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Ltd | 616,502 8.450% | 616,502 (New Position) | Filing History |
| 2024-11-14 12:24 pm Unchanged | 2024-09-30 | 13G | Kezar Life Sciences, Inc. KZR | BARCLAYS PLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-10-08 4:20 pm Unchanged | 2024-10-08 | 13D | Kezar Life Sciences, Inc. KZR | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-07-08 4:32 pm Unchanged | 2024-07-08 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 6:47 pm Unchanged | 2024-02-14 | 13G | Kezar Life Sciences, Inc. KZR | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 6:44 pm Unchanged | 2024-02-14 | 13G | Kezar Life Sciences, Inc. KZR | BARCLAYS PLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 06:50 am Unchanged | 2024-02-14 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 11:55 am Unchanged | 2024-02-13 | 13G | Kezar Life Sciences, Inc. KZR | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 09:50 am Unchanged | 2024-02-13 | 13G | Kezar Life Sciences, Inc. KZR | Prosight Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-29 3:26 pm Unchanged | 2024-01-29 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-23 09:15 am Unchanged | 2024-01-23 | 13G | Kezar Life Sciences, Inc. KZR | STATE STREET CORP STT | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-22 4:04 pm Unchanged | 2024-01-22 | 13G | Kezar Life Sciences, Inc. KZR | MILLENNIUM MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |